Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones

Jul 24, 2025

DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. (REGN) advanced 2.04% to $572.39 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.78% to 6,358.91 and the Dow Jones Industrial Average rising 1.14% to 45,010.29.

This was the stock's third consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 52.74% short of its 52-week high of $1,211.20, which the company reached on August 27th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 1.15% to $309.22, Moderna Inc. (MRNA) rose 5.93% to $34.67, and Gilead Sciences Inc. $(GILD.UK)$ rose 3.08% to $113.56.

Trading volume (890,585) remained 372,561 below its 50-day average volume of 1.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 23, 2025 16:47 ET (20:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2553228024"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2553228024\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2553228024?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-24 04:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2553228024","market":"other","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc. Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. (REGN) advanced 2.04% to $572.39 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index  rising 0.78% to 6,358.91 and the Dow Jones Industrial Average  rising 1.14% to 45,010.29. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 52.74% short of its 52-week high of $1,211.20, which the company reached on August 27th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> rose 1.15% to $309.22, <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. (MRNA) rose 5.93% to $34.67, and <a href=\"https://laohu8.com/S/GILD\">Gilead Sciences</a> Inc. <a href=\"https://laohu8.com/S/GILD.UK\">$(GILD.UK)$</a> rose 3.08% to $113.56. \n</p>\n<p>\n     Trading volume (890,585) remained 372,561 below its 50-day average volume of 1.3 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2025 16:47 ET (20:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-07-24 04:47</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc. Stock Outperforms Competitors On Strong Trading Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. (REGN) advanced 2.04% to $572.39 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&amp;P 500 Index  rising 0.78% to 6,358.91 and the Dow Jones Industrial Average  rising 1.14% to 45,010.29. \n</p>\n<p>\n     This was the stock's third consecutive day of gains. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 52.74% short of its 52-week high of $1,211.20, which the company reached on August 27th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> rose 1.15% to $309.22, <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. (MRNA) rose 5.93% to $34.67, and <a href=\"https://laohu8.com/S/GILD\">Gilead Sciences</a> Inc. <a href=\"https://laohu8.com/S/GILD.UK\">$(GILD.UK)$</a> rose 3.08% to $113.56. \n</p>\n<p>\n     Trading volume (890,585) remained 372,561 below its 50-day average volume of 1.3 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2025. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 23, 2025 16:47 ET (20:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元制药公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2553228024","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2553228024","pubTimestamp":1753303620,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  advanced 2.04% to $572.39 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.78% to 6,358.91 and the Dow Jones Industrial Average  rising 1.14% to 45,010.29.This was the stock's third consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 52.74% short of its 52-week high of $1,211.20, which the company reached on August 27th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  rose 1.15% to $309.22, Moderna Inc.  rose 5.93% to $34.67, and Gilead Sciences Inc.  rose 3.08% to $113.56.Trading volume  remained 372,561 below its 50-day average volume of 1.3 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWat","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"再生元制药公司股票在强劲交易日表现优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1},"content_text":"DJ Regeneron Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. (REGN) advanced 2.04% to $572.39 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.78% to 6,358.91 and the Dow Jones Industrial Average  rising 1.14% to 45,010.29. \n\n\n     This was the stock's third consecutive day of gains. \n\n\n     Regeneron Pharmaceuticals Inc. closed 52.74% short of its 52-week high of $1,211.20, which the company reached on August 27th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 1.15% to $309.22, Moderna Inc. (MRNA) rose 5.93% to $34.67, and Gilead Sciences Inc. $(GILD.UK)$ rose 3.08% to $113.56. \n\n\n     Trading volume (890,585) remained 372,561 below its 50-day average volume of 1.3 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 23, 2025. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 23, 2025 16:47 ET (20:47 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}